Publications by the researcher in collaboration with MÓNICA DÍAZ GAVILÁN (14)

2024

  1. Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

    Nature Metabolism

2022

  1. Effectiveness of an O-Alkyl Hydroxamate in Dogs with Naturally Acquired Canine Leishmaniosis: An Exploratory Clinical Trial

    Animals, Vol. 12, Núm. 19

  2. New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production

    European Journal of Medicinal Chemistry, Vol. 237

2021

  1. Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias

    Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-31

2020

  1. O-Alkyl Hydroxamates Display Potent and Selective Antileishmanial Activity

    Journal of Medicinal Chemistry, Vol. 63, Núm. 11, pp. 5734-5751

2019

  1. A nanodelivered Vorinostat derivative is a promising oral compound for the treatment of visceral leishmaniasis

    Pharmacological Research, Vol. 139, pp. 375-383

2018

  1. Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1

    Journal of Medicinal Chemistry, Vol. 61, Núm. 16, pp. 7144-7167

2014

  1. Synthesis of l -octaarginine through microencapsulated palladium-catalyzed allyl ester deprotection

    Synlett, Vol. 25, Núm. 16, pp. 2319-2322

2008

  1. Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies

    Bioorganic and Medicinal Chemistry Letters, Vol. 18, Núm. 4, pp. 1457-1460

2007

  1. A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells

    Breast Cancer Research and Treatment, Vol. 105, Núm. 3, pp. 237-246

  2. Corrigendum to "Synthesis and reactivity of (RS)-6-chloro-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)-7H- or 9H-purines bearing a nitrobenzenesulfonyl group on the nitrogen atom". [Tetrahedron 63 (2007) 5274] (DOI:10.1016/j.tet.2007.03.155)

    Tetrahedron

2006

  1. Study of the factors that control the ratio of the products between 5-fluorouracil, uracil, and tetrahydrobenzoxazepine O,O-acetals bearing electron-withdrawing groups on the nitrogen atom

    Journal of Organic Chemistry, Vol. 71, Núm. 3, pp. 1043-1054

  2. Synthesis and anticancer activity studies of novel 1-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)uracil and (6′-substituted)-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or 9H-purines

    Tetrahedron, Vol. 62, Núm. 50, pp. 11724-11733

2004

  1. Synthesis of tetrahydrobenzoxazepine acetals with electron-withdrawing groups on the nitrogen atom. Novel scaffolds endowed with anticancer activity against breast cancer cells

    Tetrahedron, Vol. 60, Núm. 50, pp. 11547-11557